2nd Quarter - Report

OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Mental Health, 42 CFR Part 2 (CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS) Polycystic Kidney Disease, Mental Health

LobbyistCovered position, as disclosed
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Natl Institutes of Health (NIH); SENATE

Medicare/Medicaid MMM

Part D Rule - Medicare's 6 Protected Classes

LobbyistCovered position, as disclosed
ORKIDEH MALKOC —

Contacted: SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.